Has Motaz Moussa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,846 in general payments to Motaz Moussa, MD across 155 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Motaz Moussa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Motaz Moussa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Motaz Moussa, MD

Interventional Cardiology · Davenport, FLNPI 1306178256

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,422 of the $5,846 with a category attached, or 75.6%. 23 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 24.7% of the total. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.

$5,846in general payments, 2019–2025

Across 155 payments — averaging $37.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

W. L. Gore & Associates, Inc.$1K
Abiomed$831
Boston Scientific$828
Abbott$794
Medtronic$399
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$295
plus $1K from 17 others

What the payments were for

Travel & lodging$1,42424%
Food & beverage$4,42276%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
W. L. Gore & Associates, Inc.	5	$1,445
Abiomed	14	$831
Boston Scientific	39	$828
Abbott	29	$794
Medtronic	12	$399
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	15	$295
Inari Medical, Inc.	2	$223
Teleflex LLC	2	$199
Novartis	8	$158
Johnson & Johnson	4	$140
Amgen	5	$75
Boehringer Ingelheim	3	$63
Baxter Healthcare	2	$55
Cardiovascular Systems Inc.	3	$54
Scpharmaceuticals Inc.	1	$44
Sanofi-aventis U.S. LLC	2	$42
Edwards Lifesciences	1	$38
Stryker	1	$38
AstraZeneca	2	$32
E.r. Squibb & Sons, L.L.C.	2	$31
Braemar Manufacturing, LLC	1	$27
Esperion Therapeutics, Inc.	1	$22
Cook Medical LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,846 in reported general payments places this provider in the 35th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Medicare billing

Part B allowed, 2024

$84,938

Medicare patients

461

Services billed

1,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	34	$47,662
Metoprolol Tartrate	69	$423
Atorvastatin Calcium	33	$311
Amiodarone Hcl	14	$291
ClopidogrelClopidogrel Bisulfate	45	$242
Metoprolol Succinate	17	$222
Lisinopril	32	$92
Losartan Potassium	17	$73
Furosemide	18	$53
Amlodipine Besylate	12	$32

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Davenport

Arthur LeeGainesville$1.8M
Santhosh MathewsBradenton$1.4M
Siddharth WayangankarJacksonville$1.2M
Patrick CambierTrinity$901K
Zahid AminOrlando$635K
Rohit AminPensacola$560K
Eduardo de MarchenaMiami$498K
Dominick AngiolilloJacksonville$387K
Miguel DiazHialeah$383K
Douglas EbersoleLakeland$373K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →